Alternative Endocytic Pathway for Immunoglobulin A Fc Receptors (CD89) Depends on the Lack of FcRγ Association and Protects against Degradation of Bound Ligand
about
Secretory immunoglobulin A: from mucosal protection to vaccine development.The human immunoglobulin A Fc receptor FcαRI: a multifaceted regulator of mucosal immunity.Regulation of the tyrosine phosphorylation of Phospholipid Scramblase 1 in mast cells that are stimulated through the high-affinity IgE receptorThe conundrum of inhibitory signaling by ITAM-containing immunoreceptors: potential molecular mechanisms.Fcalpha receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-Iga complexes in patients and CD89 transgenic miceFc receptor genes and the systemic lupus erythematosus diathesis.Neutrophils in antibody-based immunotherapy of cancer.Functional expression of IgA receptor FcalphaRI on human platelets.Dysfunctions of the Iga system: a common link between intestinal and renal diseases.Immunoglobulin A: A next generation of therapeutic antibodies?Negative regulation of inflammatory responses by immunoglobulin A receptor (FcαRI) inhibits the development of Toll-like receptor-9 signalling-accelerated glomerulonephritis.Role of IgA receptors in the pathogenesis of IgA nephropathy.Endocytosis of FcalphaR is clathrin and dynamin dependent, but its cytoplasmic domain is not required.c-Jun activating binding protein 1 binds to the IgA receptor and modulates protein levels of FcalphaRI and FcRgamma-chain.Alternative splicing of myeloid IgA Fc receptor (Fc alpha R, CD89) transcripts in inflammatory responses.Fc receptor gamma chain residues at the interface of the cytoplasmic and transmembrane domains affect association with FcalphaRI, surface expression, and function.Fc receptor gamma-chain, a constitutive component of the IL-3 receptor, is required for IL-3-induced IL-4 production in basophils
P2860
Q33805948-AE32D543-4600-48D9-8231-6B0B1A78BB0BQ34218284-FF02F203-020A-4188-978B-E271037A2F5AQ34301573-AF8EEAE2-E400-42C0-8F49-F7282F70F93CQ34388481-960035AC-C90B-4C94-80D0-E948B40DDB92Q36404662-E7F86BC0-0DB7-4CA1-A1F3-CD4BB2B00F7CQ37030631-3A3ED24B-6C88-474D-8A81-9F37820686FBQ37032641-2050ECB3-215B-439E-B695-ABDCB62EF60FQ37039019-79925E8C-8C4E-4E89-873B-FF50860C33B1Q37833496-16B814DF-1E4D-467C-89B5-F9B6E27DEE52Q37892323-702E2E2E-8698-4570-B6C1-EF5A9FA50663Q38331240-B02D8143-C069-4C44-B16F-6FA0C6A6C6CAQ38634418-A0199EC9-DA16-4BF9-B547-1221150C37C8Q39783154-29BDA9A4-BDF9-4D51-9DAF-5A0FF368C84BQ42827375-EAFE89F5-CD3B-48B5-93C5-D806B945CF94Q44298231-A92B11E9-74F8-4EC0-8A3A-56746067FBCBQ47735264-E7AAA7C9-5727-4047-AB9F-A3EAD7FBE43BQ54833632-BC53E3C8-E6E2-4C12-A8F3-63670F6AD8E9
P2860
Alternative Endocytic Pathway for Immunoglobulin A Fc Receptors (CD89) Depends on the Lack of FcRγ Association and Protects against Degradation of Bound Ligand
description
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
im März 1999 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published in Journal of Biological Chemistry
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 1999
@uk
name
Alternative Endocytic Pathway ...... st Degradation of Bound Ligand
@en
Alternative Endocytic Pathway for Immunoglobulin A Fc Receptors
@nl
type
label
Alternative Endocytic Pathway ...... st Degradation of Bound Ligand
@en
Alternative Endocytic Pathway for Immunoglobulin A Fc Receptors
@nl
prefLabel
Alternative Endocytic Pathway ...... st Degradation of Bound Ligand
@en
Alternative Endocytic Pathway for Immunoglobulin A Fc Receptors
@nl
P2093
P2860
P50
P356
P1476
Alternative endocytic pathway ...... st degradation of bound ligand
@en
P2093
P2860
P304
P356
10.1074/JBC.274.11.7216
P407
P577
1999-03-01T00:00:00Z